glp 1 agonist gastric emptying GLP-1 receptor agonists and delayed emptying: implications for invasive cardiac interventions and surgery TrimRX | GLP-1 vs GIP:

About half (54%) of all adults who have taken GLP-1 drugs say it was difficult to afford the cost, including one in five (22%) who say it was very difficult. While most insured adults who have taken these drugs say their insurance covered at least part of the cost, even among insured adults about half (53%) say the cost was difficult to afford 2

One of the most pressing regulatory issues in the GLP-1 space centers on compounded formulations, which have expanded access and affordability but fall outside the rigorous oversight applied to branded medications

states combined

This is significant because current lupus nephritis management relies heavily on immunosuppressants (mycophenolate, cyclophosphamide, voclosporin) and biologics (belimumab, rituximab)

doi: 10.1038/362075a0 52 HanWNHlscherCYuanLYangWWangXHWuMNet al